2050
N. V. Dubrovina et al.
PAPER
1H NMR (CDCl3): d = 0.92–1.44 (6 H, m), 1.75–1.84 (1 H, m), 2.63
(1 H, s), 3.30–3.38 (1 H, m), 3.90 (1 H, m), 4.15–4.24 (1 H, m),
7.03–7.74 (20 Harom, m).
13C NMR (CDCl3): d = 28.7 (CH2), 31.2 (CH2), 36.6 (CH2), 41.3
(CH), 59.6 (CH), 67.6 (CH), 72.6 (OCH2), 128.2–134.3 (Carom),
141.2 (Carom), 143.3 (Carom).
was used without purification for complexation to rhodium; yield:
1.73 g (92%); [a]D25 –38 (c = 0.8, CHCl3).
1H NMR (C6D6): d = 0.62–1.11 (6 H, m), 1.45–1.55 (1 H, m), 1.77
(3 H, s, CH3), 1.86 (3 H, s, CH3), 2.96–3.08 (1 H, m), 3.27 (1 H, s),
3.58–3.64 (1 H, m), 3.82–3.97 (1 H, m), 6.71–7.78 (18 Harom, m).
13C NMR (C6D6): d = 21.5 (CH3), 28.6 (CH2), 31.2 (CH2), 36.6
(CH2), 41.3 (CH), 59.6 (CH), 67.5 (CH), 72.5 (OCH2), 128.5–134.2
(Carom), 139.0–139.5 (Carom), 141.4 (Carom).
31P NMR (CDCl3): d = 38.3 (s, NP), 114.9 (s, OP).
MS (70 eV): m/z (%) = 495 ([M]+, 19), 310 ([M – PPh2]+, 27), 293
([M – HOPPh2]+, 89), 183 ([PPh2]+, 100).
31P NMR (C6D6): d = 38.3 (s, NP), 115.7 (s, OP).
Anal. Calcd for C31H31NOP2 (495.54): C, 75.13; H, 6.30; N, 2.82;
P, 12.50. Found: C, 74.22; H, 5.72; N, 2.83; P, 12.72.
MS (70 eV): m/z (%) = 523 ([M]+, 20), 310 ([M – P(p-Tol)2]+, 18),
293 ([M – HOP(p-Tol)2], 100), 213 ([P(p-Tol)2]+, 36), 183 ([PPh2]+,
65).
(1R,3S,4S)-2-Bis(4-methylphenyl)phosphinyl-3-bis(4-methyl-
phenyl)phosphinyloxymethyl-2-azabicyclo[2.2.1]heptane (1b)
Yield: 1.92 g (97%); [a]D25 –40 (c = 0.8, CHCl3).
1H NMR (C6D6): d = 1.00–1.58 (6 H, m), 1.92–1.97 (1 H, m), 2.20
(6 H, s, CH3), 2.32 (6 H, s, CH3), 2.79 (1 H, s), 3.43–3.51 (1 H, m),
3.98–4.08 (1 H, m), 4.28–4.38 (1 H, m), 7.00–7.81 (16 Harom, m).
13C NMR (C6D6): d = 21.6 (CH3), 28.7 (CH2), 31.5 (CH2), 36.6
(CH2), 41.3 (CH), 59.8 (CH), 67.5 (CH), 72.6 (CH2O), 127.7–132.5
(Carom), 134.1 (Carom), 136.2 (Carom), 137.7–139.5 (Carom), 142.1
(Carom).
31P NMR (C6D6): d = 37.8 (s, NP), 115.4 (s, OP).
MS (70 eV): m/z (%) = 551 ([M]+, 15), 338 ([M – P(p-Tol)2]+, 22),
321 ([M – HOP(p-Tol)2]+, 69), 229 ([OP(p-Tol)2]+, 63), 213 ([P(p-
Tol)2]+, 100).
The compound was characterized as its BH3-complex
C33H41B2NOP2 (551.25) by MS and elemental analysis.
MS (70 eV): m/z (%) = 537 ([M – BH3]+, 26), 536 ([M – BH4]+, 78),
213 ([P(p-Tol)2]+, 39), 183 ([PPh2]+, 100).
Anal. Calcd for C33H41B2NOP2 (551.25): C, 71.90; H, 7.50; N, 2.54;
P, 11.24: Found: C, 70.55; H, 7.59; N, 2.40; P, 10.98.
[Rh(COD)1a–d]BF4
Aminophosphine phosphinite 1a–d (3.0 mmol) was dissolved in
THF (10 mL) and slowly added to a solution of [Rh(COD)acac]
(0.93 g, 3.0 mmol) in THF (20 mL). The solution was stirred for 15
min. Then a stoichiometric amount of aq 8 M HBF4 was added and
the stirring was continued for another 15 min. The complex was pre-
cipitated by Et2O and crystallized from THF–Et2O.
[Rh(COD)(1a)]BF4
Yield: 1.98 g (83%).
(1R,3S,4S)-2-Diphenylphosphinyl-3-bis(4-methylphenyl)phos-
phinyloxymethyl-2-azabicyclo[2.2.1]heptane (1c)
A mixture of the amino alcohol 3 (0.455 g, 3.59 mmol) and (di-
methylamino)(diphenyl)phosphine (0.83 g, 3.61 mmol) in xylene (5
mL) was refluxed for 12 h. To this solution (diethylamino)[bis(4-
methylphenyl)]phosphine (1.03 g, 3.61 mmol) was added at r.t. and
the mixture was refluxed for another 12 h. The solvent was removed
under vacuum to give the product as a colorless oil. This product
was used without purification for complexation to rhodium; yield:
1.73 g (92%); [a]D25 –45 (c = 0.8, CHCl3).
13C NMR (CDCl3): d = 26.8 (CH2), 28.4 (CH2), 29.7, 30.3, 31.1,
32.5 (CH2, COD), 37.8 (CH2), 41.9 (CH), 62.8 (CH), 63.8 (CH),
70.8 (OCH2), 94.8, 103.2, 104.6, 108.2 (=CH, COD), 128.7–136.3
(Carom).
31P NMR (CDCl3): d = 66.9 [dd, J(P,Rh) = 162 Hz, J(P,P) = 36 Hz,
NP], 127.3 [dd, J(P,Rh) = 173 Hz, J(P,P) = 36 Hz, OP].
FAB-MS: m/z (%) = 706 ([M – BF4]+, 60), 598 ([M – BF4 – COD]+,
100).
1H NMR (C6D6): d =1.10–1.58 (6 H, m), 1.91–2.22 (1 H, m), 2.29
(3 H, s, CH3), 2.36 (3 H, s, CH3), 2.74–2.84 (1 H, m), 3.42–3.52 (1
Anal. Calcd for C39H43BF4NOP2Rh (794.43): C, 58.96; H, 5.45; N,
1.76; P, 7.79; Rh, 12.95. Found: C, 58.67; H, 5.64; N, 1.71; P, 7.71;
Rh, 11.54.
H, m), 4.00–4.12 (1 H, m), 4.27–4.39 (1 H, m), 7.13–7.86 (18 Harom
m).
,
13C NMR (C6D6): d = 21.5 (CH3), 28.7 (CH2), 31.5 (CH2), 36.6
(CH2), 41.4 (CH), 59.8 (CH), 67.5 (CH), 72.4 (OCH2), 129.4–134.2
(Carom), 138.0–140.3 (Carom), 143.4 (Carom).
31P NMR (C6D6): d = 37.9 (s, NP), 114.8 (s, OP).
[Rh(COD)(1b)]BF4
Yield: 1.81 g (71%).
13C NMR (CDCl3): d = 22.1 (CH3), 27.1 (CH2), 28.4 (CH2), 29.8,
30.2, 31.0, 32.6 (CH2, COD), 37.7 (CH2), 41.9 (CH), 62.5 (CH),
64.1 (CH), 70.7 (m, OCH2), 94.7, 102.3, 104.7, 106.5 (=CH, COD),
129.3–135.8 (Carom), 141.6 (Carom).
MS (70 eV): m/z (%) = 523 ([M]+, 29), 338 ([M – PPh2]+, 28), 321
([M – HOPPh2 ]+, 92), 213 ([P(p-Tol)2]+, 100), 183 ([PPh2]+, 40).
The compound was characterized analytically as its BH3-complex.
31P NMR (CDCl3): d = 66.5 8dd, J(P,Rh) = 161 Hz, J(P,P) = 35 Hz,
NP], 126.3 [dd, J(P,Rh) = 175 Hz, J(P,P) = 35 Hz, OP].
MS (70 eV): m/z (%) = 537 ([M – BH3]+, 43), 536 ([M – BH4]+, 82),
213 ([P(p-Tol)2]+, 100), 183 ([PPh2]+, 60).
FAB-MS: m/z (%) = 762 ([M – BF4]+, 100), 654 ([M – BF4 –
COD]+, 95).
Anal. Calcd for C33H41B2NOP2 (551.25): C ,71.90; H, 7.50; N, 2.54;
P, 11.24. Found: C, 71.81; H, 7.37; N, 2.44; P, 11.50.
Anal. Calcd for C43H51BF4NOP2Rh (849.54): C, 60.79; H, 6.05; N,
1.64; P, 7.29; Rh, 12.11. Found: C, 58.66; H, 6.02; N, 2.03; P, 7.24;
Rh, 11.99.
(1R,3S,4S)-2-Bis(4-methylphenyl)phosphinyl-3-diphenylphos-
phinyloxymethyl-2-azabicyclo[2.2.1]heptane (1d)
A mixture of the amino alcohol 3 (0.455 g, 3.59 mmol) and (dieth-
ylamino)[bis(4-methylphenyl)]phosphine (1.03 g, 3.61 mmol) in
xylene (5 mL) was refluxed for 12 h. To this solution (dimethylami-
no)(diphenyl)phosphine (0.83 g, 3.61 mmol) was added at r.t. and
the mixture was refluxed for another 12 h. The solvent was removed
under vacuum to give the product as a colorless oil. This product
[Rh(COD)(1c)]BF4
Yield: 1.63 g (66%).
13C NMR (CDCl3): d = 22.0 (CH3), 26.9 (CH2), 28.4 (CH2), 29.9,
30.1, 31.3, 32.5 (CH2, COD), 37.7 (CH2), 41.9 (CH), 62.5 (CH),
63.7 (CH), 70.7 (OCH2), 95.0, 102.3, 104.4, 106.5 (=CH, COD),
129.3–135.8 (Carom), 140.8 (Carom).
Synthesis 2004, No. 12, 2047–2051 © Thieme Stuttgart · New York